The featured speakers will showcase drug testing in humanized mouse models in two therapeutic areas: food allergy and inflammatory bowel diseases (IBD).
TORONTO (PRWEB) January 10, 2023
The drug development process strongly relies on the predictivity of preclinical mouse modeling. Humanized mouse models, i.e., mouse models that recapitulate human components are therefore highly valuable translational tools.
In this webinar, the featured speakers will showcase drug testing in humanized mouse models in two therapeutic areas: food allergy and inflammatory bowel diseases (IBD):
1. Inflammatory bowel diseases, which include ulcerative colitis and Crohn’s disease, are characterized by a chronic inflammation of the intestinal tract. Even though conventional treatments such as immune modulators might improve the symptoms, a high number of patients do not respond to the available treatments. In the first part of the webinar, Dr. Ho Wang Yin, PhD, CIO will show how humanized mouse models help develop new therapies for IBD. She will provide an overview of chemically induced models of acute colitis (DSS and TNBS), the pros and cons of each model and a summary of typical study design.
2. Peanut allergy affects up to two percent of the pediatric population and is a high unmet medical need as peanut ingestion is the most common cause of food induced anaphylaxis in the US. Oral immunotherapy, the only US Food and Drug Administration (FDA) approved therapy, is lengthy and carries the risk of serious side effects. In the second part of the webinar, Dr. Wuillemin will demonstrate the efficacy of MY006, a passive immunotherapy developed thanks to Mabylon’s unique antibody discovery platform, for the treatment of peanut allergy in humanized mouse models.
Register for this webinar to explore the importance of using humanized mouse models for translational studies in inflammatory disorders.
Join Natascha Wuillemin, PhD, Executive Vice President Immunology at Mabylon AG; and Kiave-Yune Ho Wang Yin, PhD, Director of Innovation and Business development at TransCure bioServices, for the live webinar on Tuesday, January 24, 2023, at 11am EST (4pm GMT/UK).
For more information, or to register for this event, visit Why Use Humanized Mouse Models for Translational Studies in Inflammatory Disorders?
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Tel: +1 (416) 977-6555 x371